Novel Heart Treatment Experiment Next Week

.

Novel Heart Treatment Experiment Next Week

It has been recently revealed that a team of British surgeons at the Liverpool Heart and Chest Hospital and The Royal Liverpool University Hospital, are going to initiate a heart shrinking clinical trial. The experiment is one of a kind, which aims to increase the life expectancy of humans by shrinking the size of heart.

The experiment will be conducted next week in which the size of one of the central nerves of heart will be increased. It will further help in shrinking the size of heart and will help in improving the total life expectancy of heart.

Clinical trial on rats and dogs has already been conducted and the experiment has been successful in increasing their total life expectancy. Dr. Jay Wright, who is a consultant cardiologist at Liverpool Heart and Chest Hospital, said that they are going to fit a device in the vagus nerve and its electrical stimulation will protect the heart from the effect of the hormone adrenaline.

He further affirmed that their aim is to reverse the effect of stretching of heart for a long time. The first patient who will undergo the treatment is Carl Jordan, who himself is paramedic and has suffered many cardiac attacks.

Several heart attacks damaged his heart and have also increased its size. Jordan said that he is quite excited that he is the first person from Liverpool, who will be undergoing this novel procedure. He said that it was quite crucial for him to take this decision, as his heart problem has made him vulnerable.

He was unable to perform daily life activities, and suffered problems while breathing. “Another factor is I have a young family who, although I am the one with the illness, they too are living with it and see every day what it can do to me, so hopefully it will improve my quality of life”, he said.


Latest News

Rise in Russian Arms Sales In spite of a Drop Globally
PetSmart Sells itself with an $8.3Billion Deal
Falling Oil Prices Result in a Drop in Stocks
Shares of Amaya Fall Due to Probe Conducted by Securities Regulators
Americans Consumers Display Confidence In the Market with Gain in Sales
It’s Time to Hurry Up to Enrol in the First Phase of Affordable Care Act Health
After Merger with Alliance Boots,	Walgreen CEO will Retire
Falling Fuel Prices Lift Airline Profits But No Respite in Fares Expected
Citigroup to Pay Likely $2.7B as Legal Charge
Michael Jeffries Retires as the CEO of Abercrombie & Fitch
Deutsche Bank in Trouble Again in the U.S. for Alleged Tax Scheme
Popular Demand Brings French Toast Crunch Back on the Shelves